## CHRW: C.H. Robinson Worldwide, Inc. - XLI: Industrials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.0% in lower entry zone (4.0-10.0%), top quartile (87th pct) cross-sectional ranking. Short-term MRS_5 (1.8%) confirms momentum alignment. Strong momentum (+3.4% 5-day acceleration). Outperforming sector by 4.2%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($158.78)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Ch Robinson Worldwide stock hits all-time high at 162.82 USD**
- Source: Investing.com Canada | 20251218T150439 | Bullish | Relevance: 100%
- C.H. Robinson Worldwide Inc. (CHRW) stock achieved an all-time high of $162.82 USD, surpassing its 52-week high, driven by strong investor confidence and positive market sentiment. Despite appearing overvalued by InvestingPro, the company maintains a "GOOD" financial health score and has consistently paid dividends for 29 years. Recent strong earnings and analyst upgrades further reinforce its robust performance and strategic growth initiatives.

**2. Oak Thistle LLC Makes New $999,000 Investment in C.H. Robinson Worldwide, Inc. $CHRW**
- Source: MarketBeat | 20251219T112707 | Somewhat-Bullish | Relevance: 100%
- Oak Thistle LLC has made a new $999,000 investment in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW), purchasing 7,548 shares during the third quarter. Other institutional investors have also adjusted their positions in the transportation company, with several analysts issuing ratings and price target changes. The company recently reported its quarterly earnings, exceeding analyst estimates, and increased its quarterly dividend.

**3. Ch Robinson Worldwide stock hits all-time high at 162.82 USD**
- Source: Investing.com Nigeria | 20251218T150833 | Bullish | Relevance: 100%
- C.H. Robinson Worldwide Inc. (CHRW) stock has reached an all-time high of $162.82 USD, reflecting strong investor confidence and significant year-over-year growth. This surge follows strong Q3 2025 earnings and multiple analyst upgrades, despite the stock appearing overvalued by some metrics. The company also announced an increased quarterly dividend, continuing its 29-year streak of dividend payments.

**4. Ch Robinson Worldwide stock hits all-time high at 162.82 USD**
- Source: Investing.com India | 20251218T150752 | Bullish | Relevance: 100%
- C.H. Robinson Worldwide Inc. (CHRW) stock has reached an all-time high of $162.82, outperforming its 52-week high and showing significant year-over-year gains. This growth is supported by strong investor confidence, positive Q3 2025 earnings exceeding analyst expectations, and several analyst upgrades with increased price targets. Despite being considered overvalued by InvestingPro, the company maintains a "GOOD" financial health score and a consistent dividend payment record.

**5. C.H. Robinson Worldwide, Inc. $CHRW Shares Bought by Nilsine Partners LLC**
- Source: MarketBeat | 20251217T112001 | Somewhat-Bullish | Relevance: 100%
- Nilsine Partners LLC significantly increased its stake in C.H. Robinson Worldwide, Inc. by 113.1% in the third quarter, acquiring an additional 6,560 shares. This move brings their total holdings to 12,359 shares, valued at approximately $1.64 million. The sentiment comes amidst recent large insider sales, a raised quarterly dividend, reported Q3 earnings beating estimates, and a "Moderate Buy" consensus from analysts.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Stifel | $184 | $155 | +19% |
| 2025-12-16 | Barclays | $200 | $145 | +38% |
| 2025-12-08 | Morgan Stanley | $85 | $77 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Stifel | main | Buy |
| 2025-12-16 | Barclays | up | Overweight |
| 2025-12-08 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($1.86M) |
| Sells | 2 ($0.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (-3.0%)
- First Eagle Investme: 8.9% (-0.2%)
- Blackrock Inc.: 8.2% (-8.5%)
- Wellington Managemen: 6.1% (+198.6%)
- State Street Corpora: 5.8% (-7.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +22%) could attract flows.
- Momentum building: MRS_20 improving +3.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.25 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 34%). Analyst sentiment positive (3 raises, avg +22%). Insider buying signal ($1.9M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.7B |
| Beta | 0.91 |
| 52W Range | $84.68 - $167.10 |
| Short Interest | 7.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.25 |
| Forward P/E | 27.8 |
| Current P/E | 33.4 |
| YoY Growth | 20.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 1.6% to 5.0% (+3.4% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 87th percentile. MRS_5 at 1.8% confirms short-term momentum alignment. AM_20 at 5.3% shows strong absolute momentum above own 20MA. Outperforming sector by 4.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). Elevated volume (2.0x 20MA), institutional activity likely. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.00% (CS: 88) | Strong |
| RSI_14 | 70.0 | Neutral |
| MACD Histogram | 0.21 | Bullish |
| vs SMA20 | 1.051x | Above |
| vs SMA50 | 1.129x | Above |
| vs SMA200 | 1.427x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $166.46
- **Stop Loss:** $158.78 (4.6% risk)
- **Target:** $177.98 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 117
- **Position Value:** $19,475.82
- **Portfolio %:** 19.48%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-01-28 (Est: $1.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.40 | +7.4% |
| 2025Q2 | $1.16 | $1.29 | +11.6% |
| 2025Q1 | $1.05 | $1.17 | +11.4% |
| 2024Q4 | $1.11 | $1.21 | +9.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*